Title:
ＩＬ−１８と分子標的抗体とを併用する癌治療薬
Document Type and Number:
Japanese Patent JPWO2016021720
Kind Code:
A1
Abstract:
本発明に係る癌治療薬は、ＩＬ−１８と、抗ＰＤ−Ｌ１抗体、抗ＰＤ−１抗体、抗ＰＤ−Ｌ２抗体、抗ＣＴＬＡ−４抗体、抗ＣＤ２５抗体、抗ＣＤ３３抗体および抗ＣＤ５２抗体からなる群より選ばれる１以上の抗体と、を有効成分として含有する。
More Like This:
| WO/1991/015230 | LIGAND FOR THE NEU GENE PRODUCT |
| JP2015078205 | ANTIBODIES TO OPGL |
| JP2015110669 | PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS |
Inventors:
Haruki Okamura
Kyosuke Yamanishi
Lee Wen
Kyosuke Yamanishi
Lee Wen
Application Number:
JP2016540759A
Publication Date:
May 25, 2017
Filing Date:
August 07, 2015
Export Citation:
Assignee:
Hyogo College of Medicine
International Classes:
A61K38/00; A61K39/395; A61P1/04; A61P15/00; A61P17/00; A61P21/00; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
| JP2007277242A | 2007-10-25 | |||
| JP2010522239A | 2010-07-01 |
Foreign References:
| WO2013173223A1 | 2013-11-21 | |||
| WO2004004771A1 | 2004-01-15 |
Attorney, Agent or Firm:
Harakenzo world patent & trademark
Previous Patent: 気分障害マーカーおよびその用途、ならびに統合失調症マーカーおよびそ...
Next Patent: NURSE CALL SYSTEM, NURSE CALL MASTER UNIT, AND PRIVATE BRANCH EXCHANGE
Next Patent: NURSE CALL SYSTEM, NURSE CALL MASTER UNIT, AND PRIVATE BRANCH EXCHANGE